US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 2.6300
  • +0.0400+1.54%
Close Dec 20 16:00 ET
278.54MMarket Cap-8.46P/E (TTM)

ProQR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ProQR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.990M--
--2024/Q4-- / 6.973M--
--2024/Q34.145M / 12.308M--
--2024/Q27.049M / 11.158M--
--2024/Q15.021M / 2.857M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.990M--
--2024/Q4-- / 6.973M--
--2024/Q34.145M / 12.308M--
--2024/Q27.049M / 11.158M--
--2024/Q15.021M / 2.857M--

Unlock Free Earnings Estimates

ProQR Therapeutics Earnings Reports

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7 20:03

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 26 04:13

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 8 19:04

  • ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 19:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 5, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data